The efficacy of prognostic factors derived from Ga68-PSMA PET-CT images in predicting treatment response and survival in patients with metastatic castration-resistant prostate cancer treated with Lu-177PSMA

被引：0
|
作者：
Oflas, M. [1 ]
Simsek, D. Has [1 ]
Sanli, Y. [1 ]
Kuyumcu, S. [1 ]
Isik, E. [1 ]
Karadogan, S. [1 ]
Basaran, M. [2 ]
Ekenel, M. [2 ]
Mudun, A. [1 ]
Ozkan, Z. G. [1 ]
机构：
[1] Istanbul Fac Med, Dept Nucl Med, Istanbul, Turkiye
[2] Istanbul Univ, Dept Med Oncol, Inst Oncol, Istanbul, Turkiye
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0553
引用
收藏
页码：S649 / S650
页数：2
相关论文
共 50 条
  • [1] PET/CT with 68Ga-PSMA for monitoring the treatment of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
    Heinzel, A.
    Boghos, D.
    Mottaghy, F. M.
    Gaertner, F.
    Essler, M.
    von Mallek, D.
    Ahmadzadehfar, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S23 - S23
  • [2] The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer
    Erdogan, Mehmet
    Sengul, Sevim S.
    Cetin, Bulent
    Avci, Mustafa
    Yagci, Samet
    Ozkoc, Ismail
    Barikan, Damla Ezgi
    Yildiz, Mustafa
    ANNALS OF NUCLEAR MEDICINE, 2022, 36 (06) : 562 - 569
  • [3] The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer
    Mehmet Erdogan
    Sevim S. Sengul
    Bulent Cetin
    Mustafa Avcı
    Samet Yagci
    Ismail Ozkoç
    Damla Ezgi Barikan
    Mustafa Yildiz
    Annals of Nuclear Medicine, 2022, 36 : 562 - 569
  • [4] 68Ga-PSMA PET/CT for monitoring response to 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
    Heinzel, Alexander
    Boghos, Dima
    Mottaghy, Felix M.
    Gaertner, Florian
    Essler, Markus
    von Mallek, Dirk
    Ahmadzadehfar, Hojjat
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (05) : 1054 - 1062
  • [5] 68Ga-PSMA PET/CT for monitoring response to 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
    Alexander Heinzel
    Dima Boghos
    Felix M. Mottaghy
    Florian Gaertner
    Markus Essler
    Dirk von Mallek
    Hojjat Ahmadzadehfar
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1054 - 1062
  • [6] Predictive Power of Radiomics Analysis of Pretreatment Ga-68 PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated With Lu-177 PSMA for Treatment Response and Prognosis
    Temizer, E.
    Abdulrezzak, U.
    Goksuluk, D.
    Algur, D.
    Tutus, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S777 - S777
  • [7] Pre-treatment68Ga-PSMA PET/CT Parameters Could Predict Response to177Lu-PSMA Treatment and Overall Survival in Metastatic Castration Resistant Prostate Carcinoma Patients Treated with177Lu-PSMA
    Ozkan, E.
    Demir, B.
    Ozturk, M.
    Araz, M.
    Soydal, C.
    Dursun, B.
    Urun, Y.
    Kucuk, N. O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S179 - S179
  • [8] Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer treated with 177Lu-PSMA
    Assadi, Majid
    Manafi-Farid, Reyhaneh
    Jafari, Esmail
    Keshavarz, Ahmad
    Divband, GhasemAli
    Moradi, Mohammad Mobin
    Adinehpour, Zohreh
    Samimi, Rezvan
    Dadgar, Habibollah
    Jokar, Narges
    Mayer, Benjamin
    Prasad, Vikas
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] 177Lu-PSMA-617 Treatment of Metastatic Castration-Resistant Prostate Cancer: Efficacy and Survival
    Demirci, E.
    Akyel, R.
    Sahin, O.
    Ocak, M.
    Aygun, A.
    Pehlivanoglu, H.
    Karayel, E.
    Kabasakal, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S202 - S203
  • [10] The Relation of 68Ga PSMA PET/CT Radiomics Features with Treatment Response and Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing 177Lu PSMA Radioligand Therapy
    Atalay, M.
    Coskun, N.
    Tekin, B. Okudan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S545 - S545
12345